SCHEMBL870669

SCHEMBL870669

CC(C(=O)OC=O)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 1/20 0.50
▸ PTGS2 P35354 2/20 0.45
▸ PTGS1 P23219 2/20 0.45
▸ CYP2D6 P10635 1/20 0.43
▸ HCAR2 Q8TDS4 1/20 0.42
▸ FAAH O00519 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ GRM7 Q14831 2/20 0.39
▸ BCHE P06276 1/20 0.39
▸ HTR1A P08908 1/20 0.39
▸ ADRB3 P13945 1/20 0.39
▸ HTR2A P28223 1/20 0.39
▸ HTR2C P28335 1/20 0.39
▸ DRD3 P35462 1/20 0.39
▸ HTR2B P41595 1/20 0.39
▸ HTR6 P50406 1/20 0.39
▸ POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7103276 0.85 KMT2A (0.46) KMT2APTGS2PTGS1HCAR2FAAH
SCHEMBL8079979 0.83 KMT2A (0.44) KMT2APTGS2PTGS1HCAR2FAAH
SCHEMBL7711581 0.83 KMT2A (0.44) KMT2APTGS2PTGS1HCAR2FAAH
SCHEMBL4909298 0.83 KMT2A (0.44) KMT2APTGS2PTGS1HCAR2FAAH
SCHEMBL7100460 0.80 PTGS2 (0.42) KMT2APTGS2PTGS1CYP2D6HCAR2
Acetic Acid SCHEMBL27516772 0.80 PTGS2 (0.42) KMT2APTGS2PTGS1HCAR2FAAH
Acetic Acid SCHEMBL27542169 0.80 PTGS2 (0.42) KMT2APTGS2PTGS1HCAR2FAAH
Acetic Acid SCHEMBL27420785 0.80 PTGS2 (0.42) KMT2APTGS2PTGS1HCAR2FAAH
SCHEMBL27916368 0.80 L3MBTL1 (0.52) KMT2ACYP2D6LMNAL3MBTL1POLB
SCHEMBL7651108 0.79 KMT2A (0.52) KMT2APTGS2PTGS1CYP2D6FAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190192408-A1 COMPOSITION FOR THE PERMANENT DEFORMATION OF HAIR HAVING REDUCED ODOUR WELLA OPERATIONS US, LLC 2019-06-27 — — US claimed
WO-2018053183-A1 COMPOSITION FOR THE PERMANENT DEFORMATION OF HAIR HAVING REDUCED ODOUR NOXELL CORPORATION (US) 2018-03-22 — — WO claimed
WO-2018053065-A1 COMPOSITION FOR THE PERMANENT DEFORMATION OF HAIR HAVING REDUCED ODOUR THE PROCTER & GAMBLE COMPANY (US) 2018-03-22 — — WO claimed
EP-3295925-A1 COMPOSITION FOR THE PERMANENT DEFORMATION OF HAIR HAVING REDUCED ODOUR Noxell Corporation (US) 2018-03-21 — — EP claimed
US-20070071780-A1 Personal care composition comprising a perfume booster accord PROCTER & GAMBLE COMPANY, THE 2007-03-29 — — US claimed
US-20060207037-A1 Malodor covering perfumery GIVAUDAN FRAGRANCES CORPORATION 2006-09-21 — — US claimed
CN-115572290-B Method for synthesizing ipratropium bromide by one-pot method 河北仁合益康药业有限公司 2024-11-26 — — CN disclosed
US-11896702-B2 Fragrance-enhancing compositions ALMENDRA PTE LTD. (SG) 2024-02-13 — — US disclosed
EP-4255384-A1 AQUEOUS HAIR CONDITIONER COMPOSITIONS CONTAINING SOLUBILIZED ANTI-DANDRUFF ACTIVES The Procter & Gamble Company (US) 2023-10-11 — — EP disclosed
US-11779530-B2 Composition for the permanent deformation of hair having reduced odor WELLA OPERATIONS US, LLC (US) 2023-10-10 — — US disclosed
US-20230303953-A1 CLEANING COMPOSITIONS AND USES THEREOF HENKEL AG & CO. KGAA (DE) 2023-09-28 — — US disclosed
CN-116568266-A Aqueous hair conditioner composition containing dissolved anti-dandruff active 宝洁公司 2023-08-08 — — CN disclosed
US-11672748-B2 Aqueous hair conditioner compositions containing solubilized anti-dandruff actives THE PROCTER & GAMBLE COMPANY (US) 2023-06-13 — — US disclosed
WO-2008074675-A1 EMULSIONS CONTAINING ENCAPSULATED FRAGRANCES AND PERSONAL CARE COMPOSITIONS CIBA HOLDING INC. (CH) 2008-06-26 — — WO disclosed
US-20080153736-A1 Emulsions containing encapsulated fragrances and personal care compositions comprising said emulsions BASF SE (DE) 2008-06-26 — — US disclosed
EP-1890770-A2 PERSONAL CARE COMPOSITION COMPRISING A PERFUME BOOSTER ACCORD The Procter and Gamble Company (US) 2008-02-27 — — EP disclosed
US-20080031961-A1 Benefit agent containing delivery particle PROCTER & GAMBLE COMPANY, THE 2008-02-07 — — US disclosed
US-20070071780-A1 Personal care composition comprising a perfume booster accord PROCTER & GAMBLE COMPANY, THE 2007-03-29 — — US disclosed
WO-2006138726-A2 PERSONAL CARE COMPOSITION COMPRISING A PERFUME BOOSTER ACCORD THE PROCTER & GAMBLE COMPANY (US) 2006-12-28 — — WO disclosed
CN-1369496-A Use of compound with structure similar to L-phenylalanine as medicine to treat skin diseases LU XIAODE (CN) 2002-09-18 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190192408-A1 COMPOSITION FOR THE PERMANENT DEFORMATION OF HAIR HAVING REDUCED ODOUR MAL2, MSH6, OR51E2 KMT2A 3055/4885PTGS2 1454/4885PTGS1 1224/4885
US-11779530-B2 Composition for the permanent deformation of hair having reduced odor OR51E2, MAL2, OR10J3 KMT2A 2931/4885PTGS2 2135/4885PTGS1 1779/4885
US-11672748-B2 Aqueous hair conditioner compositions containing solubilized anti-dandruff actives POLR1C, NACA, PIK3C3 KMT2A 4215/4885PTGS2 1946/4885PTGS1 1390/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback